Dure geneesmiddelen * (extramuraal), de vergoeding in 2020
- Raming voor de totale Zvw-populatie
| 2016 | 2017 | 2018 | 2019 | 2020 | ||
|---|---|---|---|---|---|---|
| Rang 2020 |
ATC-code | |||||
| 1 | J06BA02 Immunoglobuline normaal intravasculair (Nanogam ®) | 48.124.700 | 53.696.200 | 61.820.000 | 67.284.900 | 70.011.800 |
| 2 | C10AX13 Evolocumab (Repatha ®) | 5.752.200 | 20.213.900 | 33.398.200 | 39.996.800 | 47.591.400 |
| 3 | N04BA02 Levodopa met decarboxylaseremmer (Sinemet ®) | 31.931.800 | 35.995.000 | 38.668.200 | 43.362.600 | 44.404.400 |
| 4 | L04AX07 Dimethylfumaraat (Tecfidera ®) | 20.508.000 | 23.223.700 | 32.246.400 | 38.396.100 | 41.654.800 |
| 5 | R07AX30 Ivacaftor met lumacaftor (Orkambi ®) | . | 7.118.000 | 89.989.900 | 67.618.300 | 40.527.700 |
| 6 | C10AX14 Alirocumab (Praluent ®) | 1.933.100 | 9.788.000 | 20.154.600 | 30.226.600 | 40.454.100 |
| 7 | R07AX02 Ivacaftor (Kalydeco ®) | 9.158.500 | 9.238.200 | 10.484.000 | 22.191.700 | 38.708.600 |
| 8 | L04AD02 Tacrolimus (Prograft ®) | 28.406.600 | 29.571.600 | 31.591.500 | 33.166.500 | 32.387.400 |
| 9 | R07AX31 Ivacaftor met tezacaftor (Symkevi ®) | . | . | . | 12.087.100 | 30.945.000 |
| 10 | B03XA02 Darbepoetine alfa (Aranesp ®) | 24.146.400 | 24.154.600 | 26.005.200 | 28.520.300 | 29.410.500 |
| 11 | J05AR18 Emtricitabine tenofovir alafenamide elvitegravir cobicista (Genvoya ®) | 8.899.200 | 26.084.400 | 33.761.900 | 31.903.500 | 27.453.400 |
| 12 | J05AR13 Lamivudine met abacavir en dolutegravir (Triumeq ®) | 28.113.000 | 32.075.500 | 35.245.200 | 32.837.700 | 26.574.900 |
| 13 | H01CB03 Lanreotide (Somatuline ®) | 16.764.400 | 18.775.100 | 20.823.000 | 23.332.800 | 24.603.500 |
| 14 | L04AA27 Fingolimod (Gilenya ®) | 22.922.700 | 24.380.400 | 27.140.800 | 27.440.900 | 24.571.600 |
| 15 | J05AR20 Emtricitabine met tenofoviralafenamide en bictegravir (Biktarvy ®) | . | . | 866.360 | 15.886.900 | 24.468.600 |
| 16 | A09AA02 Multi-enzymen (lipase protease enz) (Creon ®) | 16.826.000 | 17.934.200 | 18.894.500 | 21.093.000 | 22.504.200 |
| 17 | C02KX04 Macitentan (Opsumit ®) | 12.536.400 | 15.307.500 | 18.914.600 | 20.294.500 | 21.476.400 |
| 18 | H01CB02 Octreotide (Sandostatine ®) | 24.451.100 | 23.379.500 | 23.427.100 | 22.712.700 | 20.796.000 |
| 19 | C09DX04 Valsartan met sacubitril (Entresto ®) | 312.930 | 2.779.800 | 6.565.300 | 12.000.000 | 19.168.400 |
| 20 | J06BA01 Immunoglobuline normaal extravasculair (Cuvitru ®) | 7.670.700 | 8.357.700 | 10.940.400 | 13.957.300 | 15.624.400 |
| 21 | L02AE02 Leuproreline (Lucrin pds ®) | 14.602.400 | 15.245.600 | 15.739.100 | 15.838.600 | 15.489.900 |
| Totaal | 323.060.130 | 397.318.900 | 556.676.260 | 620.148.800 | 658.827.000 | |